SecBot SecBot
PRESS-RELEASE ·Filed Sep 30, 2026

WVE

Wave Life Sciences USA, Inc.
BULLISH
Impact 5/10
Horizonmonths Processed27d 7h ago WireGlobeNewswire
Press release · Contract
Actionable Insight ▲ Bullish

Watch for candidate selection announcements on the three remaining collaboration programs, which would trigger additional milestone payments and validate Wave's platform further.

DirectionBullish
Confidencehigh
Horizonmonths
Latest settled — T+5d
WVE ▼ -4.32% at T+5d
LONG call ✗ call lost -4.32% · α vs SPY -6.24% · entry $3.70 → $3.54
Next anchor: T+20d in 17h
Latest observation: T+17 +1.54% FF3 residual α
Entry = T+0 close
Sep 30, 2026
via day close
T+1d
+4.86%
call +4.86% · α +4.69%
$3.88
settled 26d ago
T+5d
-4.32%
call -4.32% · α -6.24%
$3.54
settled 20d ago
T+20d
Pending
in 17h
T+60d
Pending
in 8w

Price Chart

Loading chart...

Executive Summary

Wave Life Sciences announced that GSK selected a candidate from their research collaboration for a hepatology indication, triggering a $12 million milestone payment. Three additional collaboration programs are advancing toward candidate selection, with Wave eligible for up to $330-$375 million in milestones per program plus tiered royalties.

Key Financial Metrics

Deal Value
$12.0M

Key Facts

  • GSK selected a development candidate for a hepatology indication using Wave's SpiNA design GalNAc-siRNA
  • Wave receives a $12 million milestone payment for this candidate selection
  • Wave eligible for up to $330-$375 million in development, launch, and commercial milestones per program plus tiered royalties
  • Three additional collaboration programs advancing toward candidate selection

Financial Impact

$12 million immediate milestone; up to $330-$375 million per program in future milestones plus tiered royalties

milestone revenueroyalty revenue

Risk Factors

  • Milestone payments are contingent on future development and regulatory success
  • No guarantee that remaining programs will achieve candidate selection
  • Clinical-stage biotech with no approved products; pipeline risk remains

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3371781
14 reports for WVE
Performance horizon
50% Hit rate @ T+1 2 of 4 directional calls Went positive at some point 2 of 4 best @ T+5▲ +17.42%Mar 26, 2026
Filters
Rows
Reports for WVE — sortable, filterable
TypeNow
Oct 27, 2026
today
SC 13G/A
NEUTRAL ★ 2/10
$3.50awaiting T+1—$3.44 (−1.71%)
Oct 27, 2026
today
8-K
BULLISH ★ 6/10
$3.17awaiting T+1—$3.44 (+8.52%)
Oct 27, 2026
today
Press Release
NEUTRAL ★ 5/10
$3.46awaiting T+1—$3.44 (−0.55%)
Oct 14, 2026
12d ago
DEF 14A
NEUTRAL ★ 4/10
$3.19 $3.13▼ −1.88%▼ −0.77%$3.44 (+7.84%)
Sep 30, 2026
27d ago
Press Release
BULLISH ★ 5/10
$3.70 $3.88▲ +4.86%▲ +4.69%$3.44 (−7.03%)
Aug 13, 2026
10w ago
Insider Cluster
NEUTRAL ★ 3/10
$5.41 $5.09▼ −5.92%▼ −5.44%$3.44 (−36.41%)
May 18, 2026
23w ago
Press Release
BULLISH ★ 7/10
$6.14 $6.19▲ +0.81%▼ −0.23%$3.44 (−43.97%)
Apr 28, 2026
26w ago
8-K
BULLISH ★ 7/10
$7.52 $7.05▼ −6.25%▼ −6.24%$3.44 (−54.26%)
Apr 28, 2026
26w ago
Press Release
BULLISH ★ 7/10
$7.52 $7.05▼ −6.25%▼ −6.24%$3.44 (−54.26%)
Apr 22, 2026
26w ago
Press Release
NEUTRAL ★ 1/10
$7.38 $7.31▼ −0.95%▼ −0.55%$3.44 (−53.39%)
Showing 10 of 14

US Market Status

Market Open — Closes in 54m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 30, 2026